Early Signs of Macular Degeneration: 7 Symptoms and a Self-Check You Can Do Today

The 7 earliest warning signs of AMD

AMD damages the macula — the small central part of the retina responsible for sharp, detailed vision. Because the rest of the retina is unaffected, AMD doesn't cause total blindness, but it severely impairs the central vision you need for reading, recognizing faces, and driving. The earliest signs can be subtle. Here's what to watch for:

1. Blurry or fuzzy central vision

The single most common early symptom. Your peripheral vision is fine, but the center of what you're looking at is hazy or out of focus. It feels different from a glasses-prescription problem — getting glasses doesn't fully fix it.

2. Straight lines look wavy or distorted

This is called metamorphopsia and is the most specific early sign of AMD. Door frames look bent. The edge of a table looks rippled. Lines on a page of text appear wavy. It usually appears in one eye first.

3. Dark, blurry, or empty spots in the center of your vision

A scotoma — a "blind spot" — appears in the central visual field. You might first notice it when reading: letters or words disappear into a foggy patch. Or you look at a face and the nose disappears.

4. Colors look faded or less vibrant

The macula contains the densest concentration of color-sensitive cone photoreceptors. As AMD damages these, colors look duller, less vivid. Reds especially can look brown or muted. People sometimes describe their world as "less Technicolor."

5. Increased difficulty in low light

Restaurants seem darker than they used to. Reading by a single lamp is harder. Walking from outdoors into a dimmer room, your eyes take longer to adjust. This is one of the earliest AMD complaints — often years before other symptoms.

6. Slower recovery from glare

Headlights at night feel like flashbulbs and take longer to fade from your vision than they used to. Going outdoors into bright sun is more uncomfortable. You squint more. This overlaps with normal age-related changes (we cover it on our night vision page), but it's worth flagging to your eye doctor.

7. Needing more and more light to read

You move to a brighter lamp, then a brighter one, then start reading only by daylight. This is the practical, day-to-day experience of declining macular pigment density and early AMD changes.

The Amsler grid self-check

The Amsler grid is a simple at-home test that any adult over 55 can do in 30 seconds. It is not a diagnostic tool — only an eye doctor can diagnose AMD — but it is a sensitive monitoring tool that can catch metamorphopsia (wavy lines) before you notice it in daily life.

How to do the test:

1. Print or pull up an Amsler grid (search "Amsler grid PDF" — it's a free standard image, a 10×10 grid of black lines on white with a dot in the center).
2. Wear your reading glasses if you normally use them.
3. Hold the grid about 14 inches from your face.
4. Cover one eye. Focus on the center dot with the other eye.
5. While staring at the dot, pay attention to the grid lines in your peripheral vision: are they all straight? All visible? Same darkness throughout?
6. Repeat with the other eye covered.

Warning signs on the Amsler grid:

• Wavy, bent, or distorted lines
• Lines that disappear or fade
• A dark, blurry, or empty area anywhere in the grid
• Asymmetric appearance between your two eyes

If anything looks off — call your eye doctor today. Don't wait. New metamorphopsia is a same-day-visit symptom.

For adults over 55, the American Academy of Ophthalmology recommends doing this test at least weekly if you have any AMD risk factors. It takes 30 seconds and catches early wet AMD progression that's treatable when caught fast.

Dry AMD vs. wet AMD — why the distinction matters

There are two main forms of AMD, with very different progressions and treatments:

Dry AMD (about 90% of cases)

Slow, gradual breakdown of the macular pigment and small yellow deposits (drusen) accumulating under the retina. Progresses slowly over years. No injection treatments are currently approved for early or intermediate dry AMD, but the AREDS2 nutritional protocol is associated with reduced risk of progression to advanced disease. Most diagnosed AMD is dry AMD.

Wet AMD (about 10% of cases — but causes most severe vision loss)

Abnormal blood vessels grow underneath the retina and leak fluid or blood, damaging the macula rapidly. Vision changes can happen in weeks or months instead of years. This is the version where the Amsler grid matters most — wet AMD often shows up as sudden new wavy lines or a new central blur. Treatment with anti-VEGF injections can stop the abnormal vessel growth and often preserves or slightly improves vision when started promptly.

Who's at risk for AMD?

• Age — risk rises sharply after 60
• Family history — strong genetic component; if a parent or sibling has AMD your risk is roughly 4× higher
• Smoking — single biggest modifiable risk factor; smokers have 2–4× the risk
• Cardiovascular disease, high blood pressure, high cholesterol
• Obesity and sedentary lifestyle
• Light eye color (slightly higher risk in blue/green-eyed individuals)
• Low intake of dark leafy greens (low dietary lutein and zeaxanthin)
• Significant lifetime UV exposure

When to call the eye doctor

Today, same day:

• New wavy lines on the Amsler grid or in your central vision
• A new blind spot in the center of vision
• Sudden vision loss or sudden distortion
• A "curtain" descending across your vision
• A sudden shower of new floaters or flashes of light

Within 1–2 weeks:

• Gradually worsening central vision
• Increasing difficulty in low light
• Needing more light to read than 6–12 months ago
• Family history of AMD and you're due for a routine exam

Annually (at minimum):

• Comprehensive dilated eye exam for any adult over 60
• OCT (optical coherence tomography) imaging on request if your eye doctor has AMD concerns

What slows AMD progression

This is where you have agency. Several interventions have evidence behind them:

The AREDS2 nutritional protocol

The largest clinical trial of nutrition for AMD — the AREDS2 trial conducted by the U.S. National Eye Institute — found that a specific combination of lutein, zeaxanthin, vitamins C and E, zinc, and copper was associated with reduced risk of progression to advanced AMD in adults with intermediate AMD (JAMA, 2013). This is the strongest nutritional evidence we have in vision medicine. The AREDS2 formula is specifically recommended for adults with intermediate AMD diagnosed by an eye doctor — it's not blanket-recommended as primary prevention for adults without AMD.

Stop smoking

Single biggest modifiable risk factor. Smoking dramatically accelerates AMD progression. Quitting at any age reduces risk going forward.

Eat dark leafy greens daily

Spinach, kale, collards, and Brussels sprouts are the highest dietary sources of lutein and zeaxanthin. Egg yolks are also rich. Building macular pigment density through diet is one of the few aspects of AMD risk you fully control.

Control blood pressure, cholesterol, blood sugar

Cardiovascular health and ocular health are tightly linked. The same small vessels that feed your heart also feed your retina.

UV protection daily

Sunglasses that block UV-A and UV-B are protective against the cumulative macular damage that contributes to AMD progression.

Consider a comprehensive vision supplement

For adults concerned about AMD risk but without a formal AMD diagnosis, the AREDS2 protocol isn't quite the right product — but a broader vision-support formula that includes the AREDS2 carotenoids (lutein and zeaxanthin) plus complementary ingredients (astaxanthin, bilberry, saffron, alpha lipoic acid) can support macular health alongside an annual eye exam.

We review the leading options in this category. Our top pick for 2026 is RetinaClear, which combines all four major eye-health carotenoids with the AREDS-style vitamin/mineral foundation and a botanical blend supporting ocular circulation. See our full comparison for methodology and alternatives.

Important: if you have already been diagnosed with intermediate AMD by an eye doctor, ask them whether the specific AREDS2 protocol (at the exact study doses) is right for you — that diagnosis-specific recommendation should come from your ophthalmologist, not a website.

Frequently Asked Questions